Avant Diagnostics, Inc — Operating Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/80c3f9df-6d96-4da0-991c-6686bb8d72b8/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2018 | $-2.3M | 2017-10-01 – 2018-09-30 | evidence 0001493152-19-002736 |
| FY 2017 | $-8.3M | 2016-10-01 – 2017-09-30 | evidence 0001493152-18-017043 |
| FY 2016 | $-11.6M | 2015-10-01 – 2016-09-30 | evidence 0001213900-18-011800 |
| FY 2015 | $-1.3M | 2014-10-01 – 2015-09-30 | evidence 0001213900-18-011800 |
| FY 2014 | $-34.3k | 2013-11-01 – 2014-10-31 | evidence 0001019687-15-000561 |
| FY 2013 | $-3.2M | 2008-10-16 – 2014-04-30 | evidence 0001019687-14-002523 |
| FY 2012 | $-3.0M | 2008-10-16 – 2013-04-30 | evidence 0001387131-13-002198 |
| FY 2011 | $-1.1M | 2008-10-17 – 2012-04-30 | evidence 0001144204-12-034741 |
| FY 2010 | $-363.8k | 2009-11-01 – 2010-10-31 | evidence 0001144204-12-008657 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).